- Home
- KMDA vs SDHY Comparison
KMDA vs SDHY Comparison
Compare KMDA & SDHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- SDHY
- Stock Information
- Founded
- KMDA 1990
- SDHY 2020
- Country
- KMDA Israel
- SDHY United States
- Employees
- KMDA N/A
- SDHY N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- SDHY Finance/Investors Services
- Sector
- KMDA Health Care
- SDHY Finance
- Exchange
- KMDA Nasdaq
- SDHY Nasdaq
- Market Cap
- KMDA 380.7M
- SDHY 382.7M
- IPO Year
- KMDA N/A
- SDHY N/A
- Fundamental
- Price
- KMDA $6.89
- SDHY $16.40
- Analyst Decision
- KMDA Strong Buy
- SDHY
- Analyst Count
- KMDA 3
- SDHY 0
- Target Price
- KMDA $14.67
- SDHY N/A
- AVG Volume (30 Days)
- KMDA 53.8K
- SDHY 94.0K
- Earning Date
- KMDA 05-14-2025
- SDHY 01-01-0001
- Dividend Yield
- KMDA 2.89%
- SDHY 8.46%
- EPS Growth
- KMDA 66.67
- SDHY N/A
- EPS
- KMDA 0.25
- SDHY 1.07
- Revenue
- KMDA $160,953,000.00
- SDHY N/A
- Revenue This Year
- KMDA $14.01
- SDHY N/A
- Revenue Next Year
- KMDA $9.24
- SDHY N/A
- P/E Ratio
- KMDA $27.37
- SDHY $14.31
- Revenue Growth
- KMDA 12.93
- SDHY N/A
- 52 Week Low
- KMDA $4.74
- SDHY $13.93
- 52 Week High
- KMDA $9.15
- SDHY $15.50
- Technical
- Relative Strength Index (RSI)
- KMDA 58.32
- SDHY 62.93
- Support Level
- KMDA $6.69
- SDHY $15.94
- Resistance Level
- KMDA $7.10
- SDHY $16.11
- Average True Range (ATR)
- KMDA 0.16
- SDHY 0.22
- MACD
- KMDA 0.05
- SDHY 0.06
- Stochastic Oscillator
- KMDA 72.00
- SDHY 88.32
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About SDHY PGIM Short Duration High Yield Opportunities Fund
PGIM Short Duration High Yield Opportunities is a closed-end management investment company. The fund's investment objective is to provide total return, through a combination of current income and capital appreciation. Its seeks to achieve its objective by investing in a diversified portfolio of high yield fixed income instruments.